The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and FDA's Overreach on Compounded Peptides As unregulated peptides grow in popularity, doctors warn of unknown risks ABC11 Raleigh Durham